이스라엘 - 히브리어 - Ministry of Health

abic marketing ltd, israel - apomorphine hydrochloride - תמיסה להזרקה\אינפוזיה - apomorphine hydrochloride 10 mg/ml - apomorphine - apomorphine - the treatment of disabling motor fluctuations ("on-off" phenomena) in patients with parkinson's disease which persist despite individually titrated treatment with levodopa (with a peripheral decarboxylase inhibitor) and/or other dopamine agonists.

이스라엘 - 히브리어 - Ministry of Health

teva israel ltd - apomorphine hydrochloride - תמיסה להזרקה - apomorphine hydrochloride 10 mg/ml - apomorphine - apomorphine - the treatment of disabling motor fluctuations ( "on-off" phenomena) in patients with parkinson's disease which persist despite individually titrated treatment with levodopa ( with a peripheral decarboxylase inhibitor ) and/or other dopamine agonists.

이스라엘 - 히브리어 - Ministry of Health

glaxo smith kline (israel) ltd - ropinirole as hydrochloride 2 mg - film coated tablets - prolonged release - ropinirole - ropinirole is indicated for the treatment of parkinson's disease. ropinirole is effective as early therapy in patients requiring dopaminergic therapy. as adjunctive treatment to l-dopa, ropinirole enhances the efficacy of l-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic l-dopa therapy and permits reduction in daily l-dopa dose.

이스라엘 - 히브리어 - Ministry of Health

glaxo smith kline (israel) ltd - ropinirole as hydrochloride 8 mg - film coated tablets - prolonged release - ropinirole - ropinirole is indicated for the treatment of parkinson's disease. ropinirole is effective as early therapy in patients requiring dopaminergic therapy. as adjunctive treatment to l-dopa, ropinirole enhances the efficacy of l-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic l-dopa therapy and permits reduction in daily l-dopa dose.

이스라엘 - 히브리어 - Ministry of Health

glaxo smith kline (israel) ltd - ropinirole as hydrochloride 4 mg - film coated tablets - prolonged release - ropinirole - ropinirole is indicated for the treatment of parkinson's disease. ropinirole is effective as early therapy in patients requiring dopaminergic therapy. as adjunctive treatment to l-dopa, ropinirole enhances the efficacy of l-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic l-dopa therapy and permits reduction in daily l-dopa dose.

이스라엘 - 히브리어 - Ministry of Health

eldan electronic instruments co ltd - ioflupane - תמיסה להזרקה - ioflupane 74 mbq/ml - iodine ioflupane (123i) - other dopaminergic agents - datscan is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum: - of patients with clinically uncertain parkinsonian syndromes in order to help differentiate essential tremor from parkinsonian syndromes related to idiopathic parkinson's disease multiple system atrophy and progressive supranuclear palsy. - datscan is unable to discriminate between parkinson's disease multiple system atrophy and progressive supranuclear palsy. - to help differentiate probable dementia with lewy bodies from alzheimer's disease. datscan is unable to discriminate between dementia with lewy bodies and parkinson's disease dementia

이스라엘 - 히브리어 - Ministry of Health

inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 100 mg; carbidopa 25 mg; entacapone 200 mg - levodopa - levodopa - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.

이스라엘 - 히브리어 - Ministry of Health

inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 50 mg; carbidopa 12.5 mg; entacapone 200 mg - levodopa and decarboxylase inhibitor - levodopa and decarboxylase inhibitor - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.

이스라엘 - 히브리어 - Ministry of Health

abbvie biopharmaceuticals ltd, israel - carbidopa as monohydrate; levodopa - ג'ל - levodopa 20 mg/ml; carbidopa as monohydrate 5 mg/ml - levodopa - levodopa - treatment of advanced levodopa-responsive parkinson's disease with severe motor fluctuations and hyper-/dyskinesia when available combinations of parkinson medicinal products have not given satisfactory results. a positive test of the clinical response to duodopa administered via a temporary nasoduodenal tube is required before a permanent tube is inserted.

이스라엘 - 히브리어 - Ministry of Health

abbvie biopharmaceuticals ltd, israel - carbidopa as monohydrate; levodopa - ג'ל - levodopa 20 mg/ml; carbidopa as monohydrate 5 mg/ml - levodopa